Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol

NCT02877667 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-07-29

No results posted yet for this study

Summary

Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.

Conditions

  • Tattoo

Interventions

DEVICE

planar acoustic wave device

accessory to laser treatment

Sponsors & Collaborators

  • MedSource LLC

    collaborator OTHER
  • Soliton

    lead INDUSTRY

Principal Investigators

  • Chris Capelli, MD · Soliton

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-04-19
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877667 on ClinicalTrials.gov